Tower Research Capital (TRC)’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.8K | Sell |
|
|||||
|
2025
Q1 | $87.3K | Sell |
|
|||||
|
2024
Q4 | $138K | Buy |
|
|||||
|
2024
Q3 | $50.8K | Sell |
|
|||||
|
2024
Q2 | $885K | Buy |
|
|||||
|
2024
Q1 | $77.5K | Sell |
|
|||||
|
2023
Q4 | $720K | Buy |
|
|||||
|
2023
Q3 | $30.7K | Sell |
|
|||||
|
2023
Q2 | $248K | Buy |
|
|||||
|
2023
Q1 | $184K | Sell |
|
|||||
|
2022
Q4 | $245K | Buy |
|
|||||
|
2022
Q3 | $106K | Sell |
|
|||||
|
2022
Q2 | $381K | Buy |
|
|||||
|
2022
Q1 | $299K | Sell |
|
|||||
|
2021
Q4 | $448K | Buy |
|
|||||
|
2021
Q3 | $114K | Sell |
|
|||||
|
2021
Q2 | $369K | Buy |
|
|||||
|
2021
Q1 | $26K | Sell |
|
|||||
|
2020
Q4 | $83K | Buy |
|
|||||
|
2020
Q3 | $36K | Sell |
|
|||||
|
2020
Q2 | $567K | Buy |
|
|||||
|
2020
Q1 | $52K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $106K | Sell |
|
|||||
|
2019
Q1 | $173K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $8K | Buy |
|
|||||
|
2018
Q1 | $1K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $2K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $32K | Buy |
|
|||||
|
2016
Q4 | $12K | Sell |
|
|||||
|
2016
Q3 | $17K | Sell |
|
|||||
|
2016
Q2 | $21K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $3K | Buy |
|
|||||
|
2015
Q2 | $0 | Sell |
|
|||||
|
2015
Q1 | $23K | Buy |
|